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1. Introduction
Fishing is a rather ancient human activity and has played an
important role in many human societies. Since the early 1960s, the
state of fisheries has been consistently monitored by the Food and
Agriculture Organization (FAO) Fisheries Resources Division. Accord-
ing to FAO (2000), the world fish production frommarine catches has
been increasing at an yearly rate of 6%, from 1950 (ca. 19.3 million
tons) up to 1970 (ca. around 60 million tons) (Blanco, Sotelo, Chapela,
& Pérez-Martín, 2007); however, more recent data point at more than
91 million tons of fish and shellfish caught each year (Rustad, 2003).
In the 25 Member States European Union, the annual fish captures
(from fishing and aquaculture) added up to 6.9 million ton in 2003
(Fishery Statistic Data, Eurostat, 2006) and the fish processing sector
has generated an added value of EUR 3.8 billion (Eurostat, NACE,
2008).
Nowadays, an integrated and sustainable exploitation of fisheries
resources is a must as only 50% of the catch is used for actual human
consumption. Fisheries worldwide annual discards are estimated to
be ca. 20 million tons, which represent 25% of the catch (Rustad,
2003) and include “non-target” species, and processing waste and by-
products. In the European Union those discards represent a total of ca.
5.2 million tons per year (AWARENET, 2004; Mahro & Timm, 2007).
Fish filleting, salting and smoking generate the major amount of solid
waste and by-products (50–75% of the fish) with a total of
3.17 million tons per year; fish canning is regarded as the second
source of solid waste and by-products (30–65% of the fish) with an
amount of 1.5 million tons per year; crustaceans and mollusk
processing also generate significant amounts of solid residues (20–
50%), ca. 0.5 million tons per year (AWARENET, 2004). In the UK it is
estimated that ca. 313,000 tons of seafood processing residues are
produced every year, so only 43% of the catches end up as products for
human consumption (Archer, Watson, Garret, & Large, 2005).
Waste and by-products discharged by fisheries are currently rising,
driven by both a net increase in fisheries products consumption and
the changing consumer trend towards ready-to-use products. The
seafood consumption has consistently increased during recent years
as seafood has been progressively recognized as an important source
of nutrients for human health. Proteins, lipids and polysaccharides but
also minerals from seafood possess unique features some of which are
a consequence of specific environmental factors prevailing in the
marine environment, such as temperature, pressure, salt concentra-
tion and oxygen availability (Shahidi, 1997). Seafood by-products and
waste constitute at present a serious environmental problem
(Arvanitoyannis & Kassaveti, 2008); those by-products and waste
require appropriate management, especially because they are highly
perishable, owing chiefly to the action of microorganisms that there
find an excellent growth medium. Furthermore, more stringent
quality and hygienic standards enforced to industries have caused a
significant increase in the amounts of waste and wastewater
generated from seafood processing in recent years.
Major efforts have been focused on how to deal with the
aforementioned by-products and waste in efficient ways, including
useful applications; at present, most are taken advantage of as animal
feed and plant fertilizers as well as ingredients for adhesive
manufacture (AWARENET, 2004). Nutraceutical, functional food
formulation or pharmaceutical applications can also be hypothesized
as they already exist in such inexpensive marine feedstocks as head,
viscera, skin, tails, offal, blood and shells (Kim & Mendis, 2005).
Extraction of those high added value compounds (HAVC)—which can
be profitable owing to their beneficial role upon human health—
joined to the development of new technologies for recovery and
purification, will run along with concomitant benefits towards long
term sustainability of marine activities.2. High added value compounds in marine by-products and waste
By-products generated during seafood processing typically range
between 20 and 60% of starting raw material. For pelagic fish, such as
tuna, cod, mackerel, anchovy and herring, major amounts of residues
are represented by offal, head and tail (27% of the fish) collected
through eviscerating, cutting and filleting processes. Skin, bones,blood and frames are the second major residues (25% of the fish)
collected along skinning and cutting processes (AWARENET, 2004).
At present, the majority of these by-products are sent to fish meal
plants, where fish meal and fish oil are produced. Fish meal is by far
the most valuable non-edible commodity produced from marine by-
products; its global production ranges between 5.5 and 7.5 million
tons/year (Hardy & Tacon, 2002). It is a relatively dry product, used
either as animal feed or as plant fertilizer, and is composed of protein
(70%), minerals (10%), fat (10%) and water (10%), on a weight basis
(Blanco et al., 2007). The first stage of fish meal production includes
mincing, cooking and pressing of solid fish by-products, from which
wastewaters and a solid cake are generated. At a second stage, those
wastewaters are dislodged to remove any remaining solid particles,
which are then added to the solid cake, and then centrifuged to
separate the oil fraction; this crude fish oil is further processed or sold
as such. The water is fed back to the process line where the solid cake,
along with the material from the wastewater, is dried and grounded
to produce fish meal (SEAFISH, 2008). Fish oil can have edible and
non-edible applications depending on its composition. Production of
soap, glycerol, varnishes, drying and hydraulic oils, fertilizers and
substrates for fermentation, are the most common uses, whilst its
edible applications are essentially accounted for the production of
margarine and shortenings (AWARENET, 2004).
Fish meal can exhibit very diverse specifications, in terms of amino
acid profile, digestibility and palatability, depending on the raw
material and production process employed (Blanco et al., 2007). Fish
meal from pelagic fish is the most widely used, and may generate an
income up to 108 Euro/ton depending on its specific composition;
currently its average market value is 46 Euro/ton (AWARENET, 2004;
SEAFISH, 2008). The main HAVC that can be found in marine by-
products are presented in Table 1. The highest concentration of these
bioactive compounds is generally found in the parts of the marine
organisms that are discarded (AWARENET, 2004). Note that present
concentrations can attain up to 80% of the by-product in question—
especially in the case of lipids in cod liver. Table 1 also shows themean
market values for selected HAVC that, as expected, are strongly
dependent upon purity. It must be highlighted that the least
expensive HAVC—gelatin/collagen—hold a value 30-fold higher than
fish meal. Finally, for HAVC such as natural free amino acids and
hydroxyapatite, a market value has not been established yet, since
only synthetic forms have been used until now.
In the following sections, the current and potential uses of the
most important types of HAVC will be described in detail together
with reference to state-of-the-art technologies for extraction and
purification.
2.1. Polyunsaturated fatty acids ω-3
ω-3 fatty acid concentrates remain a topic of general interest for
the pharmaceutical and food industries, for the production of drugs
with enhanced performance and for the production of nutritional
supplements. As known, fat is a source of energy but is also a vital
structural component of cellular membranes and is involved in many
important cell-signaling pathways (Ma et al., 2004). Since the early
studies on long-chain ω-3 polyunsaturated fatty acids (PUFA) carried
out by Burr back in 1929, the health benefits of these compounds have
been thoroughly investigated, so their market is expected to grow
further in the future (Bimbo, 2007). Such HAVC are considered as
“essential fatty acids” due to their key role in many metabolic
processes and because they cannot be synthesized de novo by
mammalian cells (Harris, Miller, Tighe, Davidson, & Schaefer, 2007).
Dietary ω-3 PUFA ameliorates numerous biological and physiological
functions in human body, being particularly valuable in treating some
diseases (Ma et al., 2004).
In cell culture,ω-3 andω-6 PUFA are generated from the precursor
α-linolenic acid and linoleic acid, respectively (Tapiero, Ba Nguyen,
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Algae, cod liver, oil of mackerel
flesh residues





Bimbo (2007), Falch, Rustad, and Aursand (2006), Mondello, Tranchida, Dugo,
and Dugo (2006), Ward and Singh (2005), AWARENET (2004)
Free amino
acids
Mussels, fresh clams, white
fish flesh residues, crustacean
shells
0.8–2% of taurine, 2.7%
of creatine (on dry
matter)
n.a. Larsen, Stormo, Dragnes, and Elvevoll (2007), Leuchtenberger, Huthmacher, and
Drauz (2005), Heu, Kim, and Shahidi (2003)
Chitin and
chitosan
Shrimp and crab shells 15–40% 15–750 Abdou, Nagy, and Elsabee (2008), Sini, Santosh, and Mathew (2007), Kurita
(2006), AWARENET (2004), Healy, Green, and Healy (2003), Kumar (2000)
Collagen and
gelatin
Pelagic fish skin, scales and
bones
Up to 80% in skin, up to
50% in scales
9–14 Wang et al. (2008), Kim, Mendis, and Shahidi (2007), Wasswa, Tang, and Gu
(2007), AWARENET (2004)
Hydroxyapatite Pelagic fish scales and bones 60–70% in bones, up to
50% in scales




Cold water pelagic fish blood
and skin
5–35 mg/ml in cold
water fish blood
5000 Jin and DeVries (2006), AWARENET (2004), Evans and Fletcher (2004), Crevel,
Fedyk, and Spurgeon (2002)
Astaxanthin Algae, crustacean shells 2.3–33% 3000–12,000 Babu, Chakrabarti, Raja, and Sambasivarao (2008), Yang (2007), López-
Cervantes, Sánchez-Machado, Gutiérrez-Coronado, and Ríos-Vázquez (2006),
AWARENET (2004)
Enzymes Algae, pelagic fish viscera – 14,400 (cod
proteases)
SEAFISH (2008); Rasmussen and Morrissey (2007), Shahidi and JanakKamil
(2001)
n.a.—not available.Couvreur, & Tew, 2002); the former leads to eicosapentaenoic acid
(EPA, 20:5ω3) and docoesahexaenoic acid (DHA, 22:6ω3), whereas
the latter leads to arachidonic acid (AA, 20:4ω6) and other long-chain
ω-6 fatty acids (Harris et al., 2007; Tapiero et al., 2002). After
absorption in the human body, PUFA are incorporated at cellular level
into triglycerides (i.e., 3 fatty acids molecules on a glycerol backbone),
phospholipids (i.e., 2 fatty acids molecules on a phosphatidic acid
backbone) and cholesterol esters (i.e., 1 fatty acid molecule on free
cholesterol). Some studies indicate that ω-3 PUFA are most promptly
absorbed from the intestine when taken orally in the form of free fatty
acids, moderately absorbed if in the triglyceride form and poorly
absorbed if in ethyl esters form. However, ω-3 PUFA in the form of
triglycerides are the most stable and desirable for food formulation,
unlike as free fatty acids, which are easily oxidized, and as ethyl esters,Table 2
Human health effects of ω-3 polyunsaturated fatty acids EPA and DHA.
Claimed function of EPA and DHA References
Improvement of vision acuity, field of vision and
adaptation to light. Alteration of permeability,
fluidity, thickness and lipid phase properties of
retinal photoreceptor membrane (DHA only)
Harris et al. (2007),
SanGiovanni and Chew (2005)
Reduction of risk of myocardium lesion and
coronary heart disease via lowering blood
pressure, triglyceride levels and platelet
aggregation, and prevention of arrhythmias
Harris et al. (2007), Moore
et al. (2006)
Protective effects against some common cancers
(breast and colon) via inhibition of eicosanoids
synthesis
Goldberg and Katz (2007),
Rose and Connolly (1999)
Increase of level of insulin Patel et al. (2007)
Beneficial effects in sclerosis treatments via
affecting functions of central nervous system
Weinstock-Guttman et al.
(2005)
Preventive and curative effects upon
non-alcoholic fatty liver disease via lowering
liver fat content
Spadaro et al. (2008)
Increase of toleration to noxious therapies
(e.g. chemotherapy)
Morisco et al. (2007)
Decrease of heart rate beating Svensson, Schmidt, Jorgesen,
and Christensen (2007)
Improvement of emotional state (e.g. in depression
and anxiety conditions)
Raeder, Steen, and Bjelland
(2007)
Beneficial effects on autoimmune diseases
(e.g. rheumatoid arthritis, psoriasis, systemic
lupus, Crohn's disease).
Curtis, Harwood, Dent, and
Caterson (2004)
Reduction of joint pain associated with
inflammatory conditions, via inhibition of
central regulators of inflammation.
Fedacko et al. (2007), Goldberg
and Katz (2007)which continue to be unacceptable for food purposes in terms of
safety (Liu, Zhang, Hong, & Ji, 2007). Themajor reported effects ofω-3
PUFA—EPA and DHA—on human tissues are described in Table 2.
PUFA can be recovered from a number of marine by-products.
Marine protists and microalgae have been referred as the major
sources of EPA and DHA (Schizochytrium spp. for the specific recovery
of DHA; Phaeodactylum and Monodus spp. for the specific recovery of
EPA; Isochrysis galbana spp. for the recovery of both EPA and DHA)
(Robles Medina, Molina Grima, Giménez Giménez, & Ibañez González,
1998;Ward & Singh, 2005). Antarctic krill (Ju & Harvey, 2004) and by-
products from edible fish (e.g. sardine, anchovy, salmon and cod) are
the second most important sources of PUFA (Mondello et al., 2006),
followed by fish caught especially for fish meal and oil production
(Bimbo, 2007).
The most important natural sources of ω-3 PUFA are indeed fish
oils of common species such as sardine, mackerel, cod, shark and
menhaden with PUFA levels of ca. 30%, which makes them
commercially interesting raw materials to prepare ω-3 PUFA
concentrates (Chakraborty & Raj, 2007). In particular, cod liver has
for long been the most suitable marine by-product for recovery ofω-3
PUFA, for extended use as nutraceutical, having a high content of
vitamins A, D and E (Mondello et al., 2006); this oil contains high
amounts of lipids (ca. 50–80%), of which 23% is accounted for EPA
(Falch et al., 2006; Kolakowska et al., 2002). Anchovy and bluefin
possess exceptionally high DHA levels. Salmon head, which repre-
sents themain salmon by-product, is also regarded as a good source of
PUFA due to a significant content of lipids, ca. 15–18% (Huang &
Shativel, 2008). Among fish flesh, mackerel is accordingly the main
source of EPA/DHA: it yields ca. 15% (w/w) of oil, with 9% (w/w) of
PUFAs and 4% (w/w) of DHA in particular, as triglycerides (Linko &
Hayakawa, 1996). Mackerel flesh content of PUFA is in order of
1810 mg per 100 g, followed by salmon with 1800 mg per 100 g, tuna
with 1500 mg per 100 g, herring with 1200 mg per 100 g), salmon
trout with 1060 mg per 100 g and cod with 240 mg per 100 g
(Fedacko et al., 2007).
Microcapsules containingω-3 PUFA concentrates are a useful form
of PUFA supply to the human body, as they convey an extended
stability and allow for the release of the active compound in the
intestine only (Kantor, Steiner, & Pack, 1990). Microencapsulation
also eliminates the well-known unpleasant taste and smell of fish oil,
as well as its aftertaste (particularly when ingested in relatively large
quantities), and effectively prevents oxidation of PUFA. When
microencapsulation is not applied, lipid peroxidation is normally
difficult to avoid and addition of antioxidants to PUFA is required. For
preventing oxidation several combinations have been tested: the
most successful result has been achieved with a ternary antioxidant
system containing α-, γ- and δ-tocopherol concentrates (in the range
of 0.2–2.0%), ascorbic acid (or ascorbyl palmitate), soy lecithin,
quercetin, morin and catechin (Kamal-Eldin & Yanishlieva, 2002).
Other alternative solutions have also been proposed: histidine, for
instance, shows a pronounced effect towards preservation of herring
oil, whereas catechin, morin and quercetine show strong antioxida-
tive effects on sardine oil up to 60 °C (Kamal-Eldin & Yanishlieva,
2002).
Numerous methods are currently employed for ω-3 PUFA concen-
tration; however, only few are suitable for large-scale production. A
single separation/purification method is not often feasible, because the
rawmaterial is usually too heterogeneous with relatively high contents
of undesirable compounds. Nowadays, PUFA are mainly recovered as
free fatty acids, after chemical or enzymatic hydrolysis of marine oil,
followed by purification. Depending on the desired yield, available
methods include distillation (Chang, Bao, & Pelura, 1989; Shahidi &
Wanasundara, 1998), enzymatic splitting (Camacho-Páez, Robles-
Medina, Camacho, González-Moreno, & Molina-Grima, 2002; Halldors-
son, Kristinsson, & Haraldsson, 2004), low-temperature crystallization
(Harris et al., 2007; Shahidi & Wanasundara, 1998), supercritical fluid
extraction (Catchpole, Grey, & Noemark, 2000) coupled or not with
nanofiltration (Sarrade, Rios, & Carles, 1998), urea complexation
(Chakraborty & Raj, 2007; Gámez-Meza et al., 2003), and argentation
chromatography (Chakraborty & Raj, 2007;Mondello et al., 2006). Each
technique has its ownadvantages anddrawbacks and leads toω-3 PUFA
concentrates in different forms. Chromatography, crystallization and
urea complexation are useful techniques for collecting PUFA as free fatty
acids (Chakraborty & Raj, 2007; Gámez-Meza et al., 2003) whereas
supercriticalfluidextraction, distillationandalsourea complexation, are
suitable techniques for the recovery of PUFA as fatty acids esters
(Perretti et al., 2007; Shahidi & Wanasundara, 1998). PUFA as
acylglycerols can be obtained by enzymatic methods (Halldorsson et
al., 2004; Shimada, Sugihara, & Tominaga, 2001).
Distillation has been mentioned (Chang et al., 1989; Shahidi &
Wanasundara, 1998) to produce odorless and flavorless oils, with
improved flavor and oxidative stability, which contain only insignif-
icant amounts of undesirable minor constituents, such as thermal and
oxidative polymers of unsaturated glycerides, trans-isomers, conju-
gated dienes and trienes, cholesterols, pesticides and heavy metals.
Two distillation methods currently in use are: vacuum steam
distillation followed by silica gel treatment, and short-path molecular
distillation. The former cannot improve significantly the ω-3 PUFA
concentration however the resulting oil is highly pure and can already
be subjected to specific techniques such as microencapsulation
(Chang et al., 1989). Short-path molecular distillation has been used
for partial separation of fatty acid esters; it is a rather old technique,
performed at very high temperatures (250 °C) and for very short
heating intervals, in the order of seconds. This method leads to
increases in EPA and DHA concentrations up to the ranges of 16–28.4%
and 9–43% respectively, in the case of menhaden oil (Shahidi &
Wanasundara, 1998). However, theω-3 PUFA alkyl esters form cannot
be directly used for food or pharmaceutical purposes, so a further step
of conversion to fatty acids or acylglycerols is required (Shahidi &
Wanasundara, 1998).
To recover concentrated PUFA as acylglycerols, subcritical and
supercritical fluid extraction has been performed with carbon dioxide
as solvent and at various conditions depending on the fish oil initial
composition. The most interesting result was obtained at 28 °C and
7.8 MPa, with EPA showing the greatest resistance to fractionation
(Perretti et al., 2007). Note that in fish oils, EPA and DHA are
preferentially located in the middle carbon atom of the glycerol
backbone, so it has not been possible to date to achieve very high
PUFA concentration if the oil is fractionated as triacylglycerols byphysical methods (Corrêa, Peixoto, & Guaraldo Gonçalves, 2008). In
this case, as also happened with distillation, the best performance is
obtained only if oil is previously subjected to random hydrolysis and
esterification (Perretti et al., 2007), where simultaneous hydrolysis
and esterification are carried out via an alkaline catalyst (KOH or
NaOH) and an alcohol (methanol or ethanol).
Some authors (Gámez-Meza et al., 2003; Halldorsson et al., 2004)
observed that chemical methods partially destroy the natural all-cis
ω-3 PUFA structure, whilst enzymatic hydrolysis provides milder
conditions in terms of temperature, pH and pressure, and protectsω-3
PUFA against oxidation, cis-trans isomerization and double bond
migrations. When an enzymatic process is chosen, it is brought about
by lipases, i.e., glycerol ester hydrolases that catalyzes the hydrolysis
of triacylglycerols into fatty acids, partial acylglycerols and glycerol.
PUFA are firstly enriched in the free fatty acids by hydrolyzing PUFA-
containing oil with a microbial lipase (e.g., Aspergillus niger, Candida
cylindracea, Chromobacterium viscosum or Pseudomonas spp.), and
such free fatty acids are then converted to esterified forms with a
simple alcohol reaction using a lipase (Shimada et al., 2001). Due to
potential benefit of PUFA as acylglycerols, enzymatic esterification of
glycerol with individual free fatty acids EPA and DHA recovered by
hydrolysis, and purification of PUFA-containing oils is gaining
momentum; considerable attention is being given to microbial lipases
since EPA and DHA are resistant to hydrolysis by commercial lipases
(Gámez-Meza et al., 2003).
2.2. Taurine and creatine
The food and pharmaceutical industries use free amino acids to
high levels for the production of food supplements, infant and adult
formulae, drugs (European Commission, May, 2003b; Stapleton,
Charlses, Redmond, & Bouchier-Hayes, 1997), and nutraceutical
energy formulations (Bagchi, 2005). Two amino acids widely used
in the free form—taurine and creatine—will be covered by this review
paper.
2.2.1. Taurine
Taurine (or 2-aminoethanesulfonic acid, NH2–CH2–CH2–SO3H) is a
neutral β-amino acid, which is not utilized in protein synthesis but
found mostly in the free form in the human body (Redmond,
Stapleton, Neary, & Bouchier-Hayes, 1998); a small amount of taurine
is present in small peptides in the brain (Franconi, Di Leo, Bennardini,
& Ghirlanda, 2004). Taurine is the dominant free amino acid in many
living species; in terms of content, in the human body taurine is
second only to glutamic acid. Both the amine and sulphonic groups of
taurine can undergo ionization, and their dissociation constant
contributes to the biological and physiological activities showed by
taurine (Petrosian & Haroutounian, 2000). Osmotic regulation
(Chiarla & Giovannini, 2004), cell membrane stabilization (Han,
Budreau, & Chesney, 2000), body detoxification (Lourenço & Camilo,
2002), antioxidant protection (Métayer et al., 2008), immune defense
enhancement (Redmond et al., 1998) and intracellular calcium
homeostasis regulation (Takahashi, Schaffer, & Azuma, 1997) are
the biological functions reported for taurine. Central nervous system
neuromodulation (Rose, 1996), regulation of renal development and
renal function (Han et al., 2000), anti-inflammatory activity (Chiarla &
Giovannini, 2004), bile acids conjugation and choleostasis prevention
(Lourenço & Camilo, 2002), antiarrhythmic, anti-inotropic and anti-
chronotropic effects (McCarty, 2001), endocrine andmetabolic effects
(Rose, 1996) have been referred as physiological roles of taurine in
human body. As reported by Petrosian and Haroutounian (2000),
taurine can also convert lipid and lipid soluble compounds into a
water-soluble state, a characteristic that makes it an interesting
emulsifier in various food and pharmaceutical formulations.
Among water-soluble amino acids, taurine is the most heat-stable
and after glycine, is the most water-soluble among all the heat-stable
(Petrosian & Haroutounian, 2000). Although taurine is a conditional
essential amino acid for adults (Lourenço & Camilo, 2002), it is
essential for newborns (Chiarla & Giovannini, 2004), for whom the
availability of taurine is critical to assure the development of their
central nervous system and muscles (Stapleton et al., 1997). In
newborns, the normal level of taurine is provided by their mother's
milk, as it is the predominant free amino acid in human milk. It is
particularly important for preterm newborns of gestational age not
above 32 weeks, as they possess a limited capacity to convert
methionine into cysteine and hence to taurine, due to immaturity of
the liver enzymes responsible for taurine synthesis (Rose, 1996).
Since taurine is the predominant free amino acid in human milk, it is
added in milk-based infant formulae, aimed at substituting mother's
milk, at 5 mg/100 ml. On this regard, the European Scientific
Committee of Food has proposed that taurine addition to cow's milk
and any type of infant formula should not exceed 12 mg/100 ml
(European Commission, May, 2003b).
In adult human body, taurine is synthesized from methionine and
cysteine, in the presence of vitamin B6 and it is excreted through urine
and bile at daily rates of ca. 0.23 g although varying with age, sex,
renal function and clinical condition (Lourenço & Camilo, 2002). Adult
individuals are expected to exhibit an average of 1 g/kg of taurine of
body weight. However, the synthesis ability varies widely amongst
individuals: under stress conditions, such abilities may be impaired,
hence making an external supply necessary; for this reason some
authors consider taurine as a conditionally essential amino acid for
adult population.
High concentrations of taurine have been found in animal
sources; conversely, it is essentially undetectable in vegetable
matrices. Marine organisms in particular exhibit high levels of
taurine, as it is the main organic osmolite in marine species (Omura
& Inagaki, 2000). Within seafood, raw mussel is the main source of
taurine with typical levels of 655 mg/100 g, followed by fresh clams
and raw white fish flesh with 240 mg and 151 mg per 100 g,
respectively. Cooking causes no adverse effects on taurine levels in
food, due to its thermal stability (Stapleton et al., 1997). In recent
years the use of taurine has increased especially in the so called
“energy drinks”, due to particularly successful marketing strategies
(Babu, Church, & Lewander, 2008). In the case of nutraceutical
formulations, taurine is added to 400–600 mg/l (European Commis-
sion, March, 2003a) often in combination with chromium, D-ribose
and withanolides, i.e. steroidal lactones with anti-inflammatory, anti-
arthritic and anti-cancer activities (Bagchi, 2005), and also with
potassium bicarbonate or ascorbate complexes (Boynton, 2005).
Specifically in the case of drug formulation with antihypertensive
action, taurine is present as calcium taurate (NH2–CH2–CH2–SO3)–
Ca2+ in the form of an aqueous suspension (McCarty, 2001).
2.2.2. Creatine
Creatine (or methyl guanidine–acetic acid, NH2–C[=NH2+]–NH–
CH2–C[=O]–O−), is an α-amino acid synthesized from glycine,
arginine and methionine (Clark, 1998) and can exist in the free or
phoshorylated forms. It is stored in muscle tissues, mainly skeletal,
followed by heart and smooth muscles, in which 60–70% thereof
exists in the form of phosphocreatine (Clark, 1998). It is also present
in the brain, liver, kidney and testes, but in smaller amounts. For a
typical 70 kg-man, the total creatine in his body pool amounts to ca.
120 g, of which 95% is stored in the muscle (Greenhaff, 1997). In the
human body, the average rate of creatine synthesis is 1–2 g/day
(Clark, 1998), which is consumed by the normal physical activity as
this amino acid is responsible of skeletal muscle contraction and
regeneration (Bishoff & Heitz, 1994). Particularly, it provides energy
during intense muscle exercise (Bigard, 1998) and as for taurine, it
shows important biological and physiological functions, even in the
presence of some diseases. Main claimed biological roles of creatine
are neuroprotection against ischemic and oxidative insults, even inParkinson's disease (Bender, Stamtleben, & Klopstock, 2008; Sullivan,
Geiger, Mattson, & Scheff, 2000); slowing down neurodegeneration in
Huntington's disease (Bender et al., 2005) and therapeutic effects in
mitochondrial encephalomiopathies disease (Komura, Hobbiebrunken,
Wilichowsky, & Hanafeld, 2003). Physiological functions of creatine,
other than skeletal muscle regeneration and contraction, have been
referred as cardiac muscle performance maintenance (Allard, Khur-
sheed, & Sole, 2006; Gordon et al., 1995), energy provision during
intense muscular exercise (Bigard, 1998), and fat-free mass promotion
of human body (Sullivan et al., 2000).
The amino acid creatine is largely used in various food formulae,
drugs and food supplements production. At present, the latter is the
most profitable due to a widespread demand in sports at almost every
level of athletic performance (Sullivan et al., 2000).
The main marine source of creatine is found in herring with ca.
6.5 g/kg. For comparison beef and pork meat possess levels of 5.5 and
5 g/kg, respectively. Salmon and cod come second and third highest in
creatine content with ca. 4.5 and 3 g/kg on dry tissue, respectively
(Newsholme & Hardy, 1998). As a food supplement or in drug
formulation, creatine has been originally brought onto the market as a
water-soluble powder, first in the form of creatine monohydrate, (till
now the cheapest and the most widespread form), and later in more
expensive versions of creatine phosphate, citrate and malate, even in
powder form; tablets, gels, liquids, chewing gums and candies
variants are also commercialized but are less used and less efficient
as a delivery method for creatine supplementation and are more
expensive than powder (Bigard, 1998; Green & Green, 1998). In milk-
based infant formula, for instance, creatine is added as creatine
monohydrate powder up to 0.8–2 mg/100 ml (European Commission,
May, 2003b). In the recent years, a different form of creatine has been
introduced into the market: research studies reported in fact that
creatine supplements are poorly absorbed by muscle cells when
administered in its polar form, leading to the need of larger dosages.
Creatine ethyl esters, the esterified lipophilic form of creatine
monohydrate, has been reported to increase the bio-availability of
creatine since it is able to cross the muscle cells membrane easier, not
requiring the presence of creatine transporters in the human body.
However, creatine ethyl ester does not show any additional benefit to
increase muscle strength or performance than creatine monohydrate;
also, this ester form has been demonstrated to undergo an extended
hydrolysis in the gastrointestinal tract after ingestion, with a rapid
conversion in the derivative product creatinine (Fons et al., 2010;
Spillane et al., 2009).
Currently, commercial creatine and taurine are widely produced
via chemical synthesis in Europe, Asia and North America, since
natural extraction from animal and fish flesh usually incurs in higher
processing costs. Taurine is currently produced from monoethanola-
mine, sulfuric anhydride and sodium sulfate, using a relatively
expensive purification process, because taurine is insoluble in most
organic solvents commonly used in extraction and purification (Gu,
Shi, Yang, & Deng, 2004). Creatine is usually produced in the
monohydrate form, starting from sarcosine and cyanamide; however,
the final product always contains non-reacted sarcosine, for which
there is a low tolerance level by the human body, in the order of ppm,
enforced by health authorities agencies, and some other contaminant
by-products such as dicyandiamide, dihydrotriazines, creatinine, and
several ions, resulting in a formulation with a poor nutrition value.
Extraction from cold water fish protein hydrolysis appears to be a
cost-effective technology. The enzymes provided by fish offal and
viscera themselves are mixed with fish by-products in water and the
resulting enzymatic protein hydrolysate may contain up to 90% of free
amino acids, high molecular weight peptides, calcium salt and
phosphorus (Pyntikov & Salerno, 2004). The stream can be processed
by nanofiltration using inorganic membranes allowing separation of
peptides and amino acids based on membrane/solute charge
interaction (Martin-Oure, Bouhallab, & Garem, 1997). So far,
commercial developments have been reported encompassing animal
sources for free amino acids, but which resort to fermentation
processes using a highly performant strain of Escherichia coli in the
presence of sugar sources such as molasses, sucrose, or glucose
(Leuchtenberger et al., 2005). Nevertheless, marine by-products
possess great potential, as they are less affected by virus transmissible
to humans from higher warm-blooded animals.
2.3. Chitin, chitosan and their oligomers
Chitin and chitosan are ubiquitous marine polysaccharides; over
the years they have attracted a great deal of attention in food,
pharmaceutical and health applications due to their distinctive
biological and physicochemical characteristics (Kurita, 2006; Shahidi,
Arachchi, & Jeon, 1999). In fact, the last two decades have witnessed a
great amount of work on these biopolymers, which highlighted wide
potential uses (Dodane & Vilivalam, 1998). The current trend towards
the use of natural products has strongly contributed to the observed
increase in demand, which has turned chitin and chitosan production
processes into highly profitable ones. The annual production of chitin
is estimated to approach that of cellulose (Kumar, 2000), which is ca.
2.6 million tons/year (Davies, 2009).
The name ‘chitin’was firstly used by Bradconnot, back in 1811; it is
derived from the Greek word ‘chiton’, that means tunic or ‘coat of
mail’, because it was first found in the exoskeletons of insects and
crustaceans. Chitin is an odorless, white to cream-colored solid
compound with a structure similar to that of cellulose, and built from
n-acetyl-glucosamine monomers. It can exhibit various degree of
acetylation but pure chitin with full acetylation does not exist in
nature (Meyers, Chen, Yu-Min Lin, & Seki, 2008).
Depending on its source, chitin can occur as either of two
allomorphs, namely α and β forms (Rinaudo, 2006). The α type is
the most abundant and also the preferred form for industrial
applications; amongst crustaceans it is found in shrimps and crabs.
The relatively rarer β form is found in squid pen and is apparentlyTable 3
Applications of chitin, chitosan and their oligomers.
Field of application Claimed applications R











Antimicrobial agent Bactericidal Ba
Fungicidal
Mold contamination indicator
Pharmaceutical Wound healing K
Drug delivery system
Regenerative medicine (bone, skin, liver and cartilage)
Hemostatic
Edible film Respiration rate control M
Antimicrobial substances controlled release
Antioxidant controlled release
Oxygen partial pressure reduction
Temperature control
Moisture transfer control
Water purification Dyes removal G
Pesticides, phenols and PCB recovery.
Other Enzymes immobilization G
Nutraceutical encapsulation
Chromatographic separation
Analytical reagentmore reactive than the α form, yet β-chitin cannot be biosynthesized
in vitro. Bothα and β types are insoluble in water and are stable when
exposed to acids, bases or organic solvents (Dodane & Vilivalam,
1998; Malinowska & Rozylo, 1997); this water insolubility hampers
most applications of chitin (Rinaudo, 2006). Conversely, its deacety-
lated form named chitosan is soluble in several solvents, depending
on its degree of deacetylation.
Chitosan is rather soluble in acidic solutions and slightly soluble in
weak alkaline solutions (Dodane & Vilivalam, 1998); the degree of
deacetylation is once again the key parameter that dictates solubility
of chitosan in aqueous solutions. This polymer is indeed an alkaline or
neutral polysaccharide as opposed to other commercial polysacchar-
ides, such as cellulose, dextran, pectin, alginic acid, agar-agar, starch,
carrageenan, and heparin, which are all neutral or acidic (Sing & Ray,
2000); this unique feature offers a range of unique applications, as
summarized in Table 3. Chitosan possess three types of reactive
functional groups: an amino group, and primary and secondary
hydroxyl groups at C-2, C-3 and C-6 positions, respectively. Deliberate
chemical modifications of these groups have produced several
chitosan oligomers (Kurita, 2006; Shahidi et al., 1999) suitable in
various fields of applications like normal chitosan, but with tailored
features (Table 3).
Chitosan is commercially obtained mainly from chitin isolated from
shell waste of crabs, shrimp and krill (Kurita, 2006). In practice, chitin is
used almost exclusively as raw material for production of chitosan,
oligosaccharides and glucosamine, to levels that amount worldwide to
ca. 37,300 tons yearly (Chang, Chen, & Jao, 2007). Shrimp cuticle
exhibits the higher amount of chitin, i.e. 30–40%, followed by crab, i.e.
15–30%; in both cases the remaining fraction is made of proteins and
minerals (Qin & Agboh, 1997). In extraction process on the industrial
level, shells are first treated with dilute hydrochloric acid at room
temperature in order to remove metals and salts, primarily calcium
carbonate. Decalcified shells are then exposed to an alkaline media to
hydrolyse proteins and pigments (Kurita, 2006). Final polishing—via
drying—eventually leads to powdered α-chitin. Demineralization andeferences
ao, Shieh, Chang, & Chien, 2007; Muzzarelli et al., 2007
im & Thomas, 2007; Bautista-Baños et al., 2006
utista-Baños et al., 2006; Kurita, 2006
im et al., 2008; Muzzarelli et al., 2007; Salgado, Coutinho, & Reis, 2004
aher, Elsabee, Abdou, Nagy, & Eweis, 2008; No, Meyers, Prinyawiwatkul, & Xu, 2007
amage & Shahidi, 2007; Wan Ngah, Kamari, & Fatinathan, 2006
renha, Remuñán-López, Carvalho, & Seijo, 2008; Qiu & Bae, 2006
deproteination of shrimp waste can also be carried out via enzymatic
fermentation (Kurita, 2006; Sini et al., 2007); e.g., proteases derived
from Bacillus subtilis are used for chitin extraction from shrimp shells
(Sini et al., 2007), whereas Pseudomonas maltophilia seems to be
particularly effective in removing proteins from decalcified shrimp
cuticle chips (Qin & Agboh, 1997). Based on the final dried form, the
yield of this process is of the order of 30–35%, with the higher values
observed on crab shells due to the higher content of calcium carbonate
in crab cuticle.
Production of chitosan from crustacean is economically feasible,
especially if it also includes recovery of pigments such as carotenoids
(Abdou et al., 2008). To produce 1 kg of 70% deacetylated chitosan
from shrimp shells, 6.3 kg of HCl and 1.8 kg of NaOH are required, in
addition to nitrogen and water (Kumar, 2000). Chitosan is largely
produced in India, Japan, Poland, Norway and Australia from
crustacean shells, and traded under such various forms as powder,
paste, film and fiber (Sing & Ray, 2000).
Since chitin and chitosan have peculiar structures and properties
that are quite different from synthetic polymers, they have often been
considered as promising for development of desirable properties
(Kurita, 2006); however, their large molecular weight and high
viscosity restricts their in vivo use to dietary fiber. Conversely,
modified chitin and chitosan have low viscosity and are characterized
by low and short-chain length, which make them easily soluble in
neutral aqueous solutions, thus readily absorbable in vivo (Jeon,
Shahidi, & Kim, 2000). Various techniques are suitable to derivatize
chitin and chitosan; chemical or enzymatic substitution, chain
elongation and depolymerisation are the preferred methods (Senel
& McClure, 2004). Chitin and chitosan-based materials find applica-
tion usually in the form of powders and flakes, but mainly as gels for
membrane, coating, capsule, fiber, sponge and scaffold formulations.
Themethods used for chitosan and chitosan oligomers gel preparation
can be tentatively divided into five groups: solvent evaporation,
neutralization, crosslinking, ionotropic gelation and freeze-drying
(Krajewska, 2004). For all the applications, expect for use as food
fibers, chitin and chitosan are accordingly used as their oligomers,
owing to the versatility imparted by specific functional groups
(Venugopal, 2009).
2.4. Collagen and gelatin
The worldwide industrial demand for collagen and gelatin has
undergone an increasing trend and currently accounts to 326,000 tons
(Karim&Bath, 2009). Collagen is themajor structural protein present in
skins and bones of all animals where it accounts for ca. 30% of the total
protein content (Wasswa et al., 2007). Collagen is mainly sought for the
production of gelatin, a high value functional protein due to its unique
gel-forming capacity; of all hydrocolloids in use today, none is as
popular as gelatin. Despite its low biological value, gelatin, like collagen,
is commonly used in pharmaceutical and medical applications, because
of its biodegradability and biocompatibility in the physiological
environments, and also for technical applications (Young,Wong, Tabata,
& Mikos, 2005). Gelatin is hence utilized, for instance, as ingredient to
improve elasticity, consistency and stability of food, as well as for
encapsulation and film formation in the pharmaceutical, cosmetic and
photographic industries (Gómez-Guillén et al., 2000).
Gelatin is the hydrolyzed form of collagen, and is a heterogeneous
mixture of fibrous, denatured, biodegradable and water-soluble
protein, with molecular weights typically ranging between 80 and
250 kDa: it contains ca. 88% of protein, as well as 10% of moisture and
1–2% of salt, and is able to retain more than 50 times its weight of
water within its gel structure (Ying Liu, Li, & Guo, 2008). Inside gelatin
molecule, glycine is the dominant amino acid, constituting ca. 27% of
the total amino acid pool (Tabata & Ikada, 1998). Proline and
hydroxyproline come second in abundance and play a key role
towards thermal stability of collagen. The total amount of those twoimino acids is higher in mammalian (20–24%) than in fish (16–20%),
which also leads to different rheological properties. Gelatin is
amphoteric, so it possesses both acidic and alkaline properties
depending on the nature of the solution. It is relatively economical
to manufacture gelatin in large amounts since suitable raw materials
are easily available (Baziwane & He, 2003). Most gelatin in the market
is obtained from mammalian sources, typically bovine and pig skins,
which account for 46% of the world gelatin output, followed by bones
and hooves, representing 23% and 29% of the total gelatin production,
respectively; only the remaining percentage, i.e. 1%, comes from
marine sources (Karim & Bath, 2009; Wang et al., 2008). However, a
few factors recognized as a serious risk for human health, e.g., the
outbreak of bovine spongiform encephalopathy (BSE) and hoof–and–
mouth disease (FMD) (Aphtae epizooticae), which are transmissible
via food, have severely hampered the use of by-products from bovine
and porcine origin (Wang et al., 2008). Additionally, the use of land
animals as sources of gelatin is restricted by socio-cultural reasons in
some countries.
Fish by-products appear then to be a good alternative, and
furthermore show peculiar functional properties, which are depen-
dent on the fish environment which is obviously rather different from
traditional mammalian sources (Baziwane & He, 2003). Due to similar
rheological behaviors, gelatin from warm water fish can be a good
alternative to that from pork (Baziwane & He, 2003), which has been
considered to be the best among all gelatins due to its higher proline
and hydrxyproline contents (Wasswa et al., 2007). Note that collagens
derived from species living in cold environments (e.g. cod), have
lower contents of proline and hydroxyproline, so they present a lower
melting point and inferior thermal stability than those from fish that
live in warmer environments (e.g. tuna); 10% of either mammalian or
warm water fish gelatins are able to form gel at room temperature,
but 10% of cold water fish gelatin only gels at ca. −2 °C (Gildberg,
Arnesen, & Carlehog, 2002).
The final characteristics and behavior of gelatin, depends not only
on their animal origin, but also on the technology used in the
extraction process. Gelatins can be recovered from raw material
through acid, basic or enzymatic treatments, all of which are assisted
by heat and water. The acid process is preferentially used with fish
and pig skins, and is carried out with hydrochloric, sulfuric and
phosphoric acids (Ying Liu et al., 2008). In case of high number of
cross links, due to the high content of proline and hydroxyproline,
lactic acid entertains the best performance upon swelling the collagen
(Giménez, Turnay, Lizarbe, Montero, & Gómez-Guillén, 2005). High
pressures (i.e., above 200 MPa) facilitate swelling by destabilizing
acid-soluble cross links and accelerating hydrolysis of collagen
(Gómez-Guillén, Giménez, & Montero, 2005). The acid process takes
ca. 3 days and the result is a type A gelatin with a pH between 3.5 and
6, which is the most widely used. Conversely, the alkaline process
(which is employed exclusively for bovine bonds) may take up to
20 weeks and generates a type B gelatin which is harder and more
viscous than type A, and holds a pH between 5 and 7; its main
application is in stabilizing other food hydrocolloids (Wasswa et al.,
2007). After either acidic or alkaline extraction, the final gelatin is
colorless, transparent, brittle and tasteless, and is thus shapeable onto
various forms, such as sheets, flakes or powder. Despite solvent
extraction being currently the method of choice, the final gelatin
product lacks a few functional properties, so enzymatic hydrolysis has
been regarded more and more often as the best way to obtain gelatin
with given specifications. In fact, high added value mammalian and
warm water fish gelatin can be treated with proteolytic enzymes, to
produce gelatin with a very soft color, yet with high gel strength and a
wide range of viscosities (Wasswa et al., 2007).
Although collagen and gelatin from fish origin have in general a
few drawbacks when compared to their mammalian counterparts, e.g.
low stability, fishy odor and dark color, these products are well suited
for many industrial applications. Gelatin from warm water fish (e.g.
tuna, sardine and anchovy) is currently exploited as ingredient for
food and drugs coating (Pérez-Mateos, Montero, & Gómez-Guillén,
2007), in particular when odor and taste of drugs are unpleasant
(Vandervoort & Ludwing, 2004). Gelatin from warm water fish also
find application in ophthalmological formulations (Supavititpatana,
Wirjantoro, Apichartsrangkoon, & Raviyan, 2008); in production of
photographic films (Surch, Decker, & McClements, 2006) and low-set
time glues (Wasswa et al., 2007). Cold water fish (e.g. cod, hallock and
pollock) gelatin is used as structuring agent in non-gelling formula-
tions (Wasswa et al., 2007) and as active ingredient in cosmetic
preparations (Baziwane & He, 2003).
Gelatin possesses a characteristic melt-in-the-mouth property,
which make it suitable to a wide range of applications in food and
pharmaceutical industries; in particular, fish gelatin releases aroma
better and shows a higher digestibility than animal one (Gómez-Guillén
et al., 2000). Because of its solubility at room temperature, fish gelatin
permits relatively low temperature coacervation, which is not feasible
with other gelatins (Gómez-Guillén et al., 2005). Fish collagen is widely
used in beauty and cosmetic product formulation (Bae, Osatomi,
Yoshida, Osako, Yamaguchi, & Hara, 2008), mainly intended for soft
tissues (e.g. skin) as well as cartilage and bone repair (Salgado et al.,
2004). In the latter application, and as happenswith other biopolymers,
e.g. chitosan, starch and hyaluronic acid, natural collagen triggers low
immune responses, so it is a good substrate for cell adhesion, with good
capacities to interact with host tissues, owing to good chemical
versatility and chemotactic properties (Salgado et al., 2004). This
biopolymer is nowadays used in the manufacture of biocompatible
glues which consist of a mixture of collagen with citric acid as a cross
linking agent; particularly powerful in binding tissue–tissue interfaces,
yielding less toxicity than such semi-synthetic and synthetic formula-
tions as gelatin-aldehyde and cyanoacrylate-based glues (Taguchi et al.,
2006). Its intrinsically high water retention capacity is also taken
advantage of in rough skin repairing. Finally, fish and pig collagens
exhibit anti-radical action (characterized by IPOX50 of 0.18 and 0.45 mg/
mol, respectively) and a potential in decreasing blood pressure
(characterized by IC50 of 0.16 and 0.41 mg/mol, respectively) (Mor-
imura, Nagata, Uemura, Fahimi, Shigematsu, & Kida, 2002).
The intrinsic biological and physicochemical features of collagen
and gelatin make them useful in various fields. The current market
demand is surging more reliable less expensive sources, and fish by-
products clearly fit into this status.2.5. Hydroxyapatite
Research in the biomedical area has been focusing on the
identification of biomaterials with long term physiological compati-
bility, so current development of advancedmaterials with biomimetic
features is one of the most promising trends in biotechnology. The
Institute of Materials (London, UK) estimated a world market of ca.
$12,000 million per year, with an average global growth between 7
and 12% per annum (Aronov et al., 2007).
Materials obtained from natural sources obviously show the best
biocompatibility with the human body. In many circumstances,
synthetic materials are hardly accepted because the organism fights
against the invasion by foreign matter. Naturally occurring hy-
droxyapatite, Ca5(PO4)3OH, is a form of bioceramics with the highly
desirable physicochemical attributes of stability, inertness and
biocompatibility. This mineral is the primary constituent of bones,
teeth and calcified cartilage tissues in human and higher animals, as
well as fish; it represents ca. 43% of human bone, 65–70% of higher
animal bone and 60–70% of fish bone (Aronov et al., 2007; Barakat
et al., 2008). It has an elastic modulus that is ca. two orders of
magnitude greater than collagen, coupled with a density that is
three-fold that of most biological materials, which makes it suitable
for several biomedical applications.Nowadays, polymeric composites involving hydroxyapatite are
particularly demanded because of their easy tailorable manufactur-
ing processes; bioinert composites for permanent applications,
biodegradable composites for temporary applications and injectable
composites include hydroxyapatite among the main compounds,
both in pure form or as part of hybrid materials (Mano, Sousa,
Boesel, Neves, & Reis, 2004). Bone cement for craniofacial, oral-
maxillofacial and orthopedic defect repair, and coating for femoral
components are the most common applications of hydroxyapatite so
far reported (Mano et al., 2004; Salgado et al., 2004; Woodard et al.,
2007). Its beneficial osteoconductivity permits binding to human
hard tissues and thus allows implementation of very stable scaffolds
in bone as well as in tooth repair and substitution (Deville, Saiz, &
Tomsia, 2006; Moshaverinia et al., 2008). Hydroxyapatite has also
been reported in combination with other specific materials; for
instance, biodegradable metal matrix composites based on magne-
sium and hydroxyapatite, have been demonstrated to be cytocom-
patible biomaterials with adjustable mechanical and corrosive
properties, which justify their high demand for biodegradable
metal implants (Deville et al., 2006; Monkawa et al., 2006; Witte
et al., 2007). Hydroxyapatite powder has also been successfully
impregnated with cellulose sponges in attempts to obtain porous
bodies with adequate porous dimension and distribution that mimic
the morphology of a spongy bone and favor osteoconduction (Landi,
Celotti, Logroscino, & Tampieri, 2003). Other applications include
substrate for adhesion of proteins, peptides, lipids, bacteria and
strains, useful for drug delivery (Aronov et al., 2007); cartilage
regeneration (Mano et al., 2004; Woodard et al., 2007); wastewater
heavy-metal and dyes decontamination (Aronov et al., 2007).
Hydroxyapatite has classically been chemically synthesized to
tailored properties using techniques such as the hydrothermal and
sol–gel synthesis (Fathi, Hanifi, & Mortazavi, 2007). However,
hydroxyapatite obtained from natural source, as fish and animal
bones, inherits such structural properties of the original raw material,
besides the intended chemical composition, so it is a better alternative
for numerous devices based on synthetic hydroxyapatite (Haberkom
et al., 2006; Kim &Mendis, 2005). Hydrothermal alkaline hydrolysis is
the most common route for hydroxyapatite extraction from fish and
animal bones (Barakat et al., 2008). A method recently proposed for
hydroxyapatite extraction from natural sources consists of subcritical
water extraction, which has the further advantage of producing
carbonated hydroxyapatite, which is highly required in biomedical
applications. The former and more usual process also keeps the
carbonate ions of the natural hydroxyapatite source, although to a
lower extent than the subcritical water one. On the other hand,
alkaline hydrothermal process produces relatively better nanoparti-
cles (Barakat et al., 2008), which is highly desirable to human bone
applications (Li, Chen, Yin, Yao, & Yao, 2007).
Therefore, there is a continuing interest in exploring features
offered by hydroxyapatite composites, so commercial applications are
expected to rely on more accessible and less expensive raw materials
as is typically the case of fish by-products.2.6. Antifreeze proteins
Antifreeze proteins, also known as thermal hysteresis proteins, are
ice-structuring proteins able to influence the growth of ice crystals
and inhibit ice recrystallization. Those unique molecules were first
identified by de Vries back in 1969 in the blood of fish living in frozen
sea areas (Crevel et al., 2002); they apparently serve to lower fish
blood freezing point below seawater freezing point, thus avoiding the
increase in plasma osmotic pressure and without altering the blood
melting point (Barrett, 2001). Proteins with similar features have
meanwhile been found, although to lesser levels, in plants and insects
that survive at very low temperatures (Cheng, 1998).
There are two major types of antifreeze proteins: glycoproteins and
non-glycoproteins, based on presence or absence of carbohydrate,
respectively (Harding, Anderberg, & Haymet, 2003). However, both
types can lower the freezing point of an aqueous solution via a non-
colligative mechanism, by binding to the ice crystal surfaces and
inhibiting further crystal growth (Evans & Fletcher, 2004). Since
antifreeze proteins prevent fish from freezing, a significant percent is
present only in species adapted to very cold sea water; the greatest
amount has been found in the blood of Antarctic fish, particularly in cod
(Harding et al., 2003). Their antifreeze proteins are mainly glycopro-
teins, the blood concentration of which varies from 5 to 35 mg/ml (Jin &
DeVries, 2006). In both glycol- and non-glycoproteins, alaninemakes up
two-thirds of the total number of amino acid residues, with the
remaining third being accounted for threonine and cysteine.
Antifreeze proteins find large application in frozen food technol-
ogy, low-fat content food manufacture, transplanted organs cryopres-
ervation, cryosurgery and aquaculture (Feeney & Yeh, 1998;
Venketesh & Dayananda, 2008). Two applications arise as particularly
important in terms of frozen foods: ice-cream manufacturing and
frozen meat technology. Antifreeze proteins may improve quality of
frozen foods, hence allowing for the maintenance of their natural
texture, reduction of cellular damage and loss of nutrients, all of which
contributes to preserve their nutritional value (Li & Sun, 2002). It is
illustrative thatmeat (bovine and ovinemuscle) soaked in solutions of
up to 1 mg/ml of antifreeze glycoproteins prior to freezing at −20 °C
showed evidence of reduced ice crystal size, and conveyed a better
nutritional value after thawing. Furthermore, antifreeze proteins have
been used in ice-cream manufacturing to reduce the overall fat
content down to 1%, conferring a good texture thanks to their
nanostructuring ability (Feeney & Yeh, 1998). A few companies have
recently invested in this feature and consequently earned substantial
economic benefits, by designing and launching a new range of low-fat
products with pleasing texture, which are becoming even more
popular among consumers around the world due to the low caloric
content (Sigman-Grant, Warland, & Hsieh, 2003).
Although yeasts and some other types of microorganisms are a
suitable source of antifreeze proteins, the most promising one is fish.
For the recovery of such unique proteins, fish skin or blood are usually
frozen in nitrogen, powered and eventually homogenized in an
alkaline medium. After centrifugation, the lyophilized supernatant is
dissolved in the same alkaline medium, and finally is subjected to
preparative chromatography, using a specific silica gel column (Evans
& Fletcher, 2004). An alternative isolation/purification method is
adsorption on ice, using a cold finger apparatus; depending on the
intended final purity, a further chromatographic step may also be
required (Kuiper, Lankin, Gauthier, Walker, & Davies, 2003).
More performing and less expensive purification technologies are
now urged, as the final cost of 1 g of antifreeze proteins is very high,
with reported values of ca. $50 (Feeney & Yeh, 1998) to ca. $10.000Table 4





Pepsin Atlantic cod, Greenland cod, s
orange roughy
Pepsinogen Shark, tuna (bluefin), rainbow
Chymosin Harp seal




Trypsin Atlantic cod, Greenland cod, s
Atlantic white croaker, palom
Chymotrypsin Capelin, herring, Atlantic cod,
Collagenases Fiddler crab, freshwater praw
Elastases Carp, catfish, Atlantic cod
Chitinolytic enzymes Chitinases Crustaceans, squid, octopus,
Lysozymes Arctic scallop
Transglutaminases Red sea bream, rainbow trout
Lipases Shark, Atlantic cod(A/F Proteins, Walthma, USA), currently accounting for the purifica-
tion steps mainly. If that constraint is successfully addressed, a wide
diversification of the novel food portfolio employing those specialty
proteins is likely.
2.7. Enzymes
Nowadays, enzyme-based technology represents an important
contribution (and, in some cases, essential one) for many industrial
applications (Rasmussen & Morrissey, 2007). The boom in life
sciences has led worldwide industries to a sustained rate of annual
growth of ca. 7.5% for enzymes, with an estimated volume of up to US$
7000 million in 2013 (Market Research Report, 2009). This is so
because enzymes possess a high selectivity, and a very high activity
even at very low concentrations and mild conditions of pH and
temperature, which leads to fewer unwanted side-effects and by-
products (Shahidi & JanakKamil, 2001).
Aquatic invertebrates at large, as well as the internal organs of fish
and the shells of crustaceans, constitute natural sources of enzymes
with huge interest. Due to the prevailing environmental conditions,
marine enzymes can effectively operate at low temperatures, below
4 °C, and within a neutral to alkaline pH values (SEAFISH, 2008). As
emphasized elsewhere (Shahidi & JanakKamil, 2001), most enzymes
from fish and aquatic invertebrates also occur in higher animals, yet
they possess unique characteristics, in terms of molecular weight,
amino acid composition, pH and temperature stability, inhibitory
behavior and kinetic properties.
Proteases constitute at present the dominant group of marine
enzymes with a commercial expression; recall that proteases bring
about hydrolysis of peptide bonds, and have been termed as
proteinases or peptidases, depending on whether they act on proteins
or polypeptides, respectively. Gastric, intestinal and hepatopancreas
proteinases have been scrutinized more thoroughly (Beynon & Bond,
2001); pepsin from polar cod is one of the most extracted gastric
proteases, followed by collagenase, elastate, trypsin and chymotryp-
sin, as well as non proteolytic enzymes, such as transglutaminase,
lipases and chitinolytic enzymes to lower extents (Rasmussen &
Morrissey, 2007). Themain enzymes of fish, aquatic invertebrates and
marine mammals that may be potentially recovered for practical uses
are presented in Table 4.
Even though no reliable market data are presently available,
recovery of marine enzymes is potentially profitable; well established
commercial applications already exist (Table 5) but there are major
opportunities for developing new niche markets.
There is an outstanding profitablemarket for cod transglutaminase
in surimi manufacture (Shahidi & JanakKamil, 2001) as well as for
lipases in the detergent industry (Esposito et al., 2009). A recent
addition to this list is the use of lipases in polyester production
(Schmid et al., 2001). A great number of research studies are currentlyoducts (adapted from Shahidi & JanakKamil, 2001).
almon, mackerel, sardine, capelin, American smelt, tuna (bluefin),
trout
ardine, capelin, cunner, chum salmon, Atlantic salmon, Coho salmon, anchovy, carp,
eta, hybrid tilapia, krill, crayfihs, oyster
spiny dogfish, rainbow trout, scallop, abalone, white shrimp, grass carp
n, crayfish, Atlantic cod, king crab
, Atka mackerel, walleye pollok liver, scallop muscle, Botan shrimp, Squid
Table 5
Current and potential applications of enzymes obtained from marine products and
by-products (adapted from Esposito et al., 2009; Shahidi & JanakKamil, 2001).
Field of application Claimed applications
Fish curing and fermentation Fish sauce and silage production
Hydrolysed products production Fish protein hydrolysate
Flavour compound
Pigment extraction Pigments recovery from shellfish waste
Protein coagulation Rennet substitute in cheese manufacturing
Removal in milk oxidized flavor
Selective tissue degradation Fish and aquatic invertebrates deskining
Fish roe purification
Cod liver membrane removal
Shellfish exoskeleton removal
Salted cod swim bladder production
Wastewater treatment Viscosity reduction of sticky water
Detergents industry Laundry detergent production
Other potential applications Meat tenderizing
Fish oil enzymatic extraction from raw material
ω-3 fatty acids concentrates production
Antibacterial enzymes
Antioxidant enzymes
Gene cloning technologyfocusing on novel purification methods and immobilization method-
ologies that can improve both stability and enantioselectivity of the
enzymes and thus render those processes more competitive (Moha-
patra, Bapuji, & Sree, 2003).
2.8. Astaxanthin
Astaxanthin (3,3-dihydroxy-β,β-carotene-4,4-dione) is a ketocar-
otenoid oxidized from β-carotene, which plays biological roles and
possesses a number of desired features for food applications, such as
natural origin, nil toxicity, high versatility, and both hydro and
liposolubility (Delgado-Vargas & Paredes-López, 2003). Its attractive
pink color, its biological functions as vitamin A precursor and
antioxidant, make astaxanthin widely sought for food and medical
applications (López-Cervantes et al., 2006). Its superior antioxidant
power has even coined his label of “superior vitamin E”; in fact, it
possesses an antioxidant effect greater than β-carotene, as well as
vitamins C and E (Stepnowski, Olafsson, Helgason, & Jastorff, 2004),
especially in quenching singlet oxygen and scavenging free radicals.
Moreover, astaxanthin is active in protecting against chemically-
induced cancers and age-related macular degeneration, and also in
enhancing the immune system and in preventing damages arising
from ultraviolet radiation (Yang, 2007).
This carotenoid occurs naturally in a wide variety of marine and
aquatic organisms (López-Cervantes et al., 2006) with algal cells and
crustacean shells being themajor sources, followed by plants, bacteria
and egg yolk. Astaxanthin represents between 74 and 98% of the total
pigments in crustacean shells, which contains from 2.3 to 33.1 g/100 g
of carotenoids (Shahidi, Metusalach, & Brown, 1998). Due to these
high contents, crustacean shells are used not only for recovery of
chitin but also for recovery of carotenoids.
The methods currently available for the extraction of astaxanthin
from shell matrices employ different elements such as edible oils,
hydrochloric acid and organic solvents, besides proteolytic enzymes
(Babu, Chakrabarti, et al., 2008). Such plant oils as sunflower oil,
groundnut oil, ginger oil, mustard oil, soybean oil, coconut oil, rice
bran oil and palm oil have accordingly been used to extract
astaxanthin from crustaceans and fish by-products (Handayani,
Sutrisno, Indraswati, & Ismadji, 2008). Some countries, such as
India, use proteolytic enzymes, such as trypsin, papain and pepsin,
dissolved in citrate phosphate, to precipitate carotenoids from the
shells. At present, a feasible technique for partial concentration of
astaxanthin from crustacean shells is via lactic acid fermentation,
which also has the advantage of protecting the biomass from bacterialdecomposition. The silage formed contains insoluble chitin, a protein-
rich fraction, and a lipid-rich fraction composed of astaxanthin,
sterols, and vitamins A and E (Babu, Chakrabarti, et al., 2008).
Owing to its useful properties, astaxanthin from natural sources is
increasingly being marketed as a functional food ingredient in many
countries (Yang, 2007) with prices that range between 3000 and
12,000 US$/kg (AWARENET, 2004) and fish by-products are thus
expected to become increasingly important as industrial feedstock.
3. Conclusions
The dual problem arising from the surplus of several commodities,
which bear low economic returns for the farmers, while entertaining
especially in the view of increasingly tighter environmental regula-
tions, has been promoting the commercial exploitation of many
products that were so far discarded, and eventually leading to better
manufacturing practices and more sophisticated processing technol-
ogies. Valorisation of by-products arising from fish catching and
processing is a must order, since it constitutes a central issue for the
long-term sustainability of the fish industry at large. Moreover, a few
high value added compounds recovered from such type of by-
products are economically more attractive than the target products
themselves. Development of novel and clean technologies aimed at
more efficient recovery of bioactive nutraceutical compounds from
marine by-products will lead to the development of more profitable
processes, thus giving rise to many great opportunities to the marine
industry.
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